Based on cell and animal experiments, we concluded that KNTC1 can enhance the invasion, migration, and tumorigenicity of tumor cells via MMP2 and MMP9, providing a basis for the subsequent study of KNTC1 as a target for cervical cancer treatment. The gene discussed is MMP2; the disease is neoplasm.